Mary E. Rothstein

669 total citations
10 papers, 537 citations indexed

About

Mary E. Rothstein is a scholar working on Molecular Biology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mary E. Rothstein has authored 10 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Hepatology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mary E. Rothstein's work include PI3K/AKT/mTOR signaling in cancer (7 papers), Liver physiology and pathology (6 papers) and Lung Cancer Treatments and Mutations (4 papers). Mary E. Rothstein is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (7 papers), Liver physiology and pathology (6 papers) and Lung Cancer Treatments and Mutations (4 papers). Mary E. Rothstein collaborates with scholars based in United States. Mary E. Rothstein's co-authors include Laura P. Stabile, Jill M. Siegfried, Christopher T. Gubish, Ann Marie Egloff, Raja R. Seethala, Jennifer R. Grandis, Stephanie R. Land, Sufi M. Thomas, Robert L. Ferris and Lynn M. Knowles and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Molecular Pharmacology.

In The Last Decade

Mary E. Rothstein

9 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Rothstein United States 8 284 251 204 117 110 10 537
Keizo Sugimachi Japan 10 187 0.7× 234 0.9× 133 0.7× 91 0.8× 22 0.2× 14 544
W Zhang United States 12 367 1.3× 304 1.2× 115 0.6× 50 0.4× 42 0.4× 21 608
Cheng-Chung Wu Taiwan 14 146 0.5× 259 1.0× 123 0.6× 155 1.3× 21 0.2× 18 641
Helen Cawley United States 11 487 1.7× 366 1.5× 149 0.7× 16 0.1× 40 0.4× 16 812
Quentin Bayard France 9 105 0.4× 302 1.2× 105 0.5× 185 1.6× 34 0.3× 13 630
Yuichi Hisamatsu Japan 15 277 1.0× 211 0.8× 194 1.0× 16 0.1× 58 0.5× 33 631
R. Metzger United States 4 360 1.3× 300 1.2× 234 1.1× 31 0.3× 15 0.1× 4 612
Meiling Zhu China 14 137 0.5× 199 0.8× 156 0.8× 15 0.1× 30 0.3× 25 410
Annett Markwarth Germany 6 234 0.8× 242 1.0× 93 0.5× 8 0.1× 39 0.4× 7 476
Margit Gogg-Kamerer Austria 9 64 0.2× 184 0.7× 52 0.3× 60 0.5× 20 0.2× 14 452

Countries citing papers authored by Mary E. Rothstein

Since Specialization
Citations

This map shows the geographic impact of Mary E. Rothstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Rothstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Rothstein more than expected).

Fields of papers citing papers by Mary E. Rothstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Rothstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Rothstein. The network helps show where Mary E. Rothstein may publish in the future.

Co-authorship network of co-authors of Mary E. Rothstein

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Rothstein. A scholar is included among the top collaborators of Mary E. Rothstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Rothstein. Mary E. Rothstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Stabile, Laura P., Mary E. Rothstein, Christopher T. Gubish, et al.. (2014). Co-targeting c-Met and COX-2 Leads to Enhanced Inhibition of Lung Tumorigenesis in a Murine Model with Heightened Airway HGF. Journal of Thoracic Oncology. 9(9). 1285–1293. 7 indexed citations
2.
Stabile, Laura P., Mary E. Rothstein, Christopher T. Gubish, et al.. (2013). Abstract 2026: Co-targeting c-Met and COX-2 leads to enhanced inhibition of lung tumorigenesis in a murine model with heightened HGF signaling in the airways.. Cancer Research. 73(8_Supplement). 2026–2026.
3.
Siegfried, Jill M., Christopher T. Gubish, Mary E. Rothstein, Cassandra L. Henry, & Laura P. Stabile. (2012). Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 7(3). 485–495. 47 indexed citations
4.
Stabile, Laura P., Mary E. Rothstein, Diana E. Cunningham, et al.. (2012). Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens. Carcinogenesis. 33(11). 2181–2189. 39 indexed citations
5.
Stabile, Laura P., Mary E. Rothstein, Phouthone Keohavong, et al.. (2010). Targeting of Both the c-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic Mice. Cancers. 2(4). 2153–2170. 31 indexed citations
6.
Knowles, Lynn M., Laura P. Stabile, Ann Marie Egloff, et al.. (2009). HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer. Clinical Cancer Research. 15(11). 3740–3750. 175 indexed citations
7.
Hershberger, Pamela A., Laura P. Stabile, Beatriz Kanterewicz, et al.. (2009). Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 116(1-2). 102–109. 94 indexed citations
8.
Egloff, Ann Marie, Mary E. Rothstein, Raja R. Seethala, et al.. (2009). Cross-Talk between Estrogen Receptor and Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 15(21). 6529–6540. 74 indexed citations
9.
Stabile, Laura P., Mary E. Rothstein, Phouthone Keohavong, et al.. (2008). Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis. Molecular Cancer Therapeutics. 7(7). 1913–1922. 35 indexed citations
10.
Siegfried, Jill M., et al.. (2007). Signaling Pathways Involved in Cyclooxygenase-2 Induction by Hepatocyte Growth Factor in Non–Small-Cell Lung Cancer. Molecular Pharmacology. 72(3). 769–779. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keizo Sugimachi Breakdown of academic impact, for papers by W Zhang Breakdown of academic impact, for papers by Cheng-Chung Wu Breakdown of academic impact, for papers by Helen Cawley Breakdown of academic impact, for papers by Quentin Bayard Breakdown of academic impact, for papers by Yuichi Hisamatsu Breakdown of academic impact, for papers by R. Metzger Breakdown of academic impact, for papers by Meiling Zhu Breakdown of academic impact, for papers by Annett Markwarth Breakdown of academic impact, for papers by Margit Gogg-Kamerer
Rankless by CCL
2026